ISIS-DME: A prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema

Retina

Volumn 28, Issue 5, 2008, Pages 735-740

  Kim, Judy E ^a   Pollack, John S ^b   Miller, David G ^c   Mittra, Robert A ^d   Spaide, Richard F ^e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Illinois Retina Associates   (United States)

^c Retina Associates of Cleveland   (United States)

^d VitreoRetinal Surgery   (United States)

^e VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Diabetic macular edema; Injection; Intravitreal; Steroid; Triamcinolone acetonide

Indexed keywords

STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INJECTION; INTRAOCULAR PRESSURE; LOW LEVEL LASER THERAPY; MALE; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA CYSTOID EDEMA; STATISTICAL SIGNIFICANCE; VISION; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 43249106823     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318163194c     Document Type: Article

References (15)

1. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
2. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
3. Pollack JS, Packo KH. American Society of Retina Specialists 2001. Preferences and Trends Survey.
4. Mittra RA, Pollack JS. American Society of Retina Specialists 2005. Preferences and Trends Survey.
5. Lam DS, Chan KM, Mohamed S, et al. A prospective randomized trial of different doses of intravitreal triamcinolone for diabetic macular oedema. Br J Ophthalmol 2007;91:199-203.
6. Audren F, Lecleire-Collet A, Erginay A, et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: Phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 2006;142:794-799.
7. Spandau UHM, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br J Ophthalmol 2005;89:999-1003.
8. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-27.
9. Nicolo M, Nasciuti F, Lai S, et al. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series. Eur J Ophthalmol 2006;16:129-133.
10. Chan CK, Mohamed S, Shanmugam MP, et al. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol 2006;90:1137-1141.
11. Jonas JB, Spandau UH, Kamppeter BA, et al. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2006;113:800-804.
12. Audren F, Tod M, Massin P, et al. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci 2004;45:3435-3441.
13. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-686.
14. Jonas JB, Degenring RF, Kamppeter BA, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004;138:158-160.
15. Gillies MC, Sutter FKP, Simpson JM, et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006;113:1533-1538.